TRMK trades 6.4% below Wall Street's consensus target of $47.50.
Last 12 months price action with 12-month analyst target path
The base valuation assumes TRMK achieves its forward estimates and maintains a stable P/E multiple of 11.3x. This scenario reflects the blended consensus of 9 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of November 7, 2026, Trustmark Corporation (TRMK) has a Wall Street consensus price target of $47.50, based on estimates from 9 covering analysts. With the stock currently trading at $44.64, this represents a potential upside of +6.4%. The company has a market capitalization of $2.62B.
Analyst price targets range from a low of $47.00 to a high of $48.00, representing a 2% spread in expectations. The median target of $47.50 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 0 analysts rating the stock as a Buy or Strong Buy,7 rating it Hold, and 2 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, TRMK trades at a trailing P/E of 11.0x and forward P/E of 11.3x. The forward PEG ratio of 1.40 indicates reasonable valuation for growth. Analysts expect EPS to grow -0.8% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $56.30, with bear and bull scenarios of $35.47 and $74.18 respectively. Model confidence stands at 50/100, reflecting moderate uncertainty in projections.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 HOMBHome Bancshares, Inc. | $6.0B | $29.86 | $33.67 | +12.8% | Hold | 11.8x | 19 |
 SFNCSimmons First National Corporation | $3.4B | $23.34 | $25.88 | +10.9% | Buy | 11.2x | 9 |
 HOPEHope Bancorp, Inc. | $1.7B | $13.18 | $16.00 | +21.4% | Hold | 13.0x | 6 |
 IBCPIndependent Bank Corporation | $748M | $36.31 | $43.00 | +18.4% | Hold | 10.6x | 8 |
 RNSTRenasant Corporation | $3.6B | $39.39 | $48.00 | +21.9% | Buy | 10.8x | 16 |
 FFINFirst Financial Bankshares, Inc. | $4.4B | $30.41 | $34.33 | +12.9% | Hold | 14.9x | 17 |
 BOKFBOK Financial Corporation | $7.9B | $129.48 | $145.00 | +12.0% | Hold | 12.1x | 21 |
 UMBFUMB Financial Corporation | $10.2B | $133.77 | $166.44 | +24.4% | Buy | 9.9x | 19 |
 CVBFCVB Financial Corp. | $3.3B | $22.74 | $26.67 | +17.3% | Hold | 14.3x | 16 |
 BANRBanner Corporation | $2.4B | $70.09 | $75.25 | +7.4% | Hold | 11.9x | 13 |
Quick answers to the most common questions about buying TRMK stock.
The consensus price target for TRMK is $47.5, close to the current price of $44.64 (6.4% implied move). Based on 9 analyst estimates, the stock appears fairly valued near current levels.
TRMK has a consensus rating of "Hold" based on 9 Wall Street analysts. The rating breakdown is leaning bearish, with 2 Sell/Strong Sell ratings. The consensus 12-month price target of $47.5 implies 6.4% upside from current levels.
With a forward P/E of 11.275x, TRMK trades at a relatively low valuation. The consensus target of $47.5 implies 6.4% appreciation, suggesting the market may be pricing in risks.
The most bullish Wall Street analyst has a price target of $48 for TRMK, while the most conservative target is $47. The consensus of $47.5 represents the median expectation. Our quantitative valuation model projects a bull case target of $74 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
TRMK is moderately covered, with 9 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 0 have Buy ratings, 7 recommend Hold, and 2 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month TRMK stock forecast based on 9 Wall Street analysts shows a consensus price target of $47.5, with estimates ranging from $47 (bear case) to $48 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $56, with bear/bull scenarios of $35/$74.
Our quantitative valuation model calculates TRMK's fair value at $56 (base case), with a bear case of $35 and bull case of $74. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 50/100.
TRMK trades at a forward P/E ratio of 11.3x based on next-twelve-months earnings estimates compared to a trailing P/E of 11.0x. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
TRMK appears fairly valued according to analysts, with a "Hold" rating and minimal upside to the $47.5 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
TRMK analyst price targets range from $47 to $48, a 2% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $47.5 consensus represents the middle ground. Our model's $35-$74 range provides an independent fundamental perspective.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.